Mobilization of Stem Cells Using G-CSF for Acute Ischemic Stroke: A Randomized Controlled, Pilot Study

Table 4

Leukocyte counts at baseline and maximum count during hospital stay and clinical score during baseline one month, six months, and 12 months.

	Total leukocyte count		Stroke scale scores at baseline, one month/six months and 12 months
Patient no.	Baseline	Maximum during hospital stay	NIHSS	BI	mRS
G-CSF group
1	13400	40800	14/10/9	10/35/65	4/4
2	12400	—	19/−/−	5/−/−	−/−
3	7500	35400	14/9/6	45/80/85	3/3
4	7600	39200	15/7/3	25/90/95	3/2
5	8400	33400	8/9/5	40/60/80	4/3
Control group
1	7000	7000	13/10/5	15/35/55	4/4
2	13500	13500	12/10/4	55/60/75	4/3
3	8500	10400	15/12/−	20/30/55	4/4
4	7300	7300	7/2/2	55/100/100	2/1
5	10100	10100	8/4/2	15/90/95	2/2

NIHSS: National Institutes of Health stroke scale, BI: Barthel index, mRS: modified ranking scale
NIHSS score range from 0 to 42 (lower score represents better outcome and higher score represents worse outcome)
BI score range from 0 to 100 (Higher score represents the better outcome and lower score represents the worse outcome)
mRS score range from 0 to 6 (lower score represents better outcome and higher score represents worse outcome).